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INTRODUCTION
The success of an imaging-guided core needle breast 
biopsy depends on the post-biopsy management as well 
as the performance of the biopsy procedure (1). Any core 
biopsy procedure may fail to sample a cancer, resulting 
in a benign, often nonspecifi  c pathologic diagnosis, 
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despite optimization of the technique (2). Although 
there are methods such as specimen radiography or post-
biopsy mammography to confi  rm lesion retrieval after 
performing a core biopsy, they often provide incomplete 
information, especially in lesions visualized by sonography 
only. Correlation of the pathologic result with the imaging 
fi  ndings after biopsy is found to be useful to validate the 
biopsy result and to offer subsequent management (2-6). 
The purpose of this study is to review derived categories 
and corresponding management for an imaging-pathology 
correlation after performing a sonography-guided core 
needle biopsy and to illustrate the selected images for each 
category, which will provide guidance in the application of 
this post-biopsy assessment in practice.
Assessment for Concordance
Before beginning the biopsy procedure, all imaging 
features of a targeted lesion, mammography, sonography, 
and MRI, should be carefully reviewed. Moreover, the Korean J Radiol 12(2), Mar/Apr 2011 www.kjronline.org 233
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Categories of Concordance in Imaging-
Pathology Correlation
The imaging and pathologic fi  ndings are considered 
to be concordant when the pathologic result provides 
an acceptable explanation for the imaging feature and 
discordant when they do not. After the assessment for 
concordance has been completed, a management plan can 
be provided. Parikh and Tickman (4) described fi  ve possible 
outcomes of imaging-pathology correlation and suggested 
corresponding management for each category.
Category 1. Concordant Malignancy
A lesion which showed a suspicious fi  nding for 
malignancy on images (i.e., Breast Imaging Reporting and 
Data System [BI-RADS] category 4 or 5) and is diagnosed 
to be malignant on a subsequent core needle biopsy is a 
concordant malignancy (4) (Fig. 1). Within this category, 
diagnosis criteria for the fi  nding in question as well as 
setting the probability of malignancy based on these set 
criteria should be predetermined (7). When the pathology 
result is received after biopsy, the radiologist can compare 
the pathologic diagnosis with the expected result from the 
imaging fi  nding. Images documented during the biopsy 
should also be carefully reviewed to verify whether the 
lesion was accurately targeted with regard to sampling the 
wrong lesion, suboptimal sampling (i.e., patient movement 
or insuffi  cient penetration), and procedural complications 
(i.e., bleeding or hematoma formation) (1, 4, 7). A 
strong working relationship between the radiologist and 
pathologist is important for imaging-pathology correlation. 
The pathologist is critical in assessing and communicating 
the quantitative and qualitative aspects of the biopsy (1, 4).
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Fig. 1. 46-year-old woman with 
palpable mass in her right breast. 
A. On mammography (left: mediolateral 
oblique view, right: craniocaudal view), 
irregular ill-defi  ned hyperdense mass 
(arrows) is seen on area corresponding to 
palpable abnormality. B. On sonography 
(left: transverse view, right: longitudinal 
view), mass is determined to be round 
microlobulated hypoechoic mass with 
nonparallel orientation and classifi  ed as BI-
RADS category 4c. Result of sonography-
guided 14-gauge core needle biopsy are 
consistent with invasive ductal carcinoma, 
which is considered as concordant 
malignancy. C. Histologic features on low power view indicate invasive ductal carcinoma with peripheral intraductal component (arrows) without 
microcalcifi  cation. Surrounding breast parenchyma shows fatty changes (Hematoxylin & Eosin staining; original magnifi  cation, × 10).Korean J Radiol 12(2), Mar/Apr 2011 www.kjronline.org 234
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appropriate action should be taken without any delay. The 
radiologist should communicate the biopsy result to the 
referring physician, and the patient should be informed 
of the results and referred to a surgeon or oncologist for 
proper treatment.
Category 2. Discordant Malignancy 
A lesion which typically had benign or benign-favoring 
imaging features (i.e., BI-RADS category 2 or 3) but 
proves to be malignant at core needle biopsy falls into this 
category (Fig. 2). Case management should be identical 
to that for a concordant malignancy (2, 4). Lesions that 
usually lie at the circumscribed end of the malignant 
spectrum can simulate benign nodules; small infi  ltrating 
ductal carcinomas, high-grade invasive ductal carcinomas 
not otherwise specifi  ed, metastatic lesions, lymphoma, 
and special-type tumors that are well circumscribed such 
as medullary carcinomas, mucinous carcinomas, and 
papillary carcinoma (8). The radiologist should notify the 
discordant result to the pathologist and ask the patient 
to review and confi  rm the diagnosis. Also, the images of 
the lesion should be reviewed for image quality, lesion 
characteristics, and missed associated features which may 
cause an underestimation of the severity of the lesion. The 
discrepancy between imaging and pathologic results should 
be discussed thoroughly.
Category 3. Concordant Benign 
A lesion which is initially thought to be benign 
radiologically (i.e., BI-RADS category 2, 3, or 4a) and also 
demonstrates benign pathology at core needle biopsy falls 
into this category (2, 4) (Fig. 3). This result can offer 
both the physician and the patient reassurance. However, 
imaging follow-up should be recommended to patients 
because of delayed false-negative diagnoses at core biopsy 
(2). Although there is no standard follow-up guideline, a 
follow-up sonography at six months after biopsy and then 
annually for at least two years can be recommended (Fig. 4).
Category 4. Discordant Benign 
A lesion in this category is suspicious for malignancy at 
imaging (i.e., BI-RADS category 4 or 5), but demonstrates 
B
A C 
Fig. 2. 46-year-old woman with mass 
in her left breast.
A. On mammography (left: mediolateral 
oblique view, right: craniocaudal view), 
there is focal asymmetry (arrows) in 
upper outer portion of left breast. B. On 
sonography (left: transverse view, right: 
longitudinal view), oval circumscribed 
hypoechoic mass (arrows) is seen 
and classifi  ed as BI-RADS category 3. 
Sonography-guided 14-gauge core needle 
biopsy was performed at request of patient 
and pathologic result is consistent with 
invasive ductal carcinoma, which is 
considered as discordant malignancy. C. 
Photomicrograph of microscopic specimen 
after surgical excision shows relatively 
well-differentiated tumor cell nests 
dispersed in desmoplastic stroma (arrows). 
No intraductal component was seen in 
submitted specimen. Final diagnosis was 
invasive ductal carcinoma (Hematoxylin & 
Eosin staining; original magnifi  cation, × 
100).Korean J Radiol 12(2), Mar/Apr 2011 www.kjronline.org 235
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benign pathologic result after performing a core needle 
biopsy (2, 4) (Figs. 5-8). Benign lesions with spiculated 
fi  ndings can simulate malignant lesions and be considered 
as differential diagnoses as follows: sclerosing adenosis, 
fat necrosis, postsurgical scar, mastitis, granular cell tumor, 
diabetic mastopathy, and sarcoidosis (8). However, the 
radiologist should give special attention to discordant 
benign lesions from which a substantial number of missed 
cancers at core needle biopsy can be detected without any 
delay in diagnosis (Figs. 6, 7). In published reports, up 
to 64% of discordant lesions after a percutaneous biopsy 
were confi  rmed as cancer by subsequent surgical excision 
(5). For a sonography-guided 14-gauge core needle biopsy, 
discordant lesions had cancer rates of up to 50% (6). If 
there is concern regarding a discordant benign lesion, it 
is prudent for the radiologist to immediately contact the 
interpreting pathologist and thoroughly communicate with 
each other. According to the discussion, the radiologist 
should notify the result and discuss the need for a repeat 
biopsy to the referring physician or the patient. A surgical 
biopsy, rather than a core needle biopsy, is recommended 
for a repeat biopsy because of the inconclusive outcome 
from the fi  rst core biopsy. Recently, the vacuum-assisted 
core needle biopsy has been reported to be an alternative 
to surgery to obtain a defi  nitive histological diagnosis for 
discordant benign lesions (9). 
Category 5. Borderline or High Risk
A lesion in this category is not malignant but is 
considered to have an increased lifetime risk for the 
development of breast cancer (e.g., atypical ductal 
hyperplasia, lobular neoplasm, radial sclerosing lesion, 
papillary lesions, possible phyllodes tumors) (2, 4) (Figs. 9, 
10). Controversy exists regarding the surgical and oncologic 
treatment for this lesion. A case-by-case approach is 
needed to manage the patient in accordance with the active 
discussion between different subspecialties (4). However, 
surgical biopsy is usually recommended regardless of 
concordance, because of the relatively high upgrade rate to 
malignancy. 
A
Fig. 3. 45-year-old woman with mass in her left breast.
A. On mammography (left: mediolateral oblique view, right: 
craniocaudal view), oval circumscribed mass (arrows) is seen in upper 
outer portion of her left breast. B. On sonography (left: transverse 
view, right: longitudinal view), oval circumscribed hypoechoic mass 
is seen and classifi  ed as BI-RADS category 3. Sonography-guided 14-
gauge core needle biopsy was performed at request of patient and 
pathologic result indicated fi  broadenoma, which is considered to be 
concordant benign lesion. However, in lieu of follow-up image, surgical 
excision was performed. C. Photomicrograph of microscopic specimen 
after surgical excision shows sharply defi  ned border with both glandular 
(arrowhead) and stromal proliferation (arrow), mainly showing 
intracanalicular growth pattern. Final diagnosis was fi  broadenoma 
(Hematoxylin & Eosin staining; original magnifi  cation, × 10).
C BKorean J Radiol 12(2), Mar/Apr 2011 www.kjronline.org 236
Ji Hyun Youk et al.
A B
C
Fig. 4. 56-year-old woman with palpable mass in her left 
breast. 
A. On sonography (left: transverse view, right: longitudinal view), oval 
circumscribed hypoechoic mass is seen classifi  ed as BI-RADS category 
3. Sonography-guided 14-gauge core needle biopsy was performed at 
request of physician and pathologic result was fi  broadenoma, which 
was considered as concordant benign. B. At 6-month follow-up, mass 
was found to have grown along with development of calcifi  cations 
and cystic change. C. Final pathological diagnosis of surgically excised 
lesion was malignant phyllodes tumor. Hypercellular stromal cells with 
atypia and mitosis (arrow) are noted (Hematoxylin & Eosin staining; 
original magnifi  cation, × 100).
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Fig. 5. 52-year-old woman with palpable mass in her right 
breast. 
A. On mediolateral oblique view of mammography, there is architectural 
distortion (arrow) in right breast. B. On sonography (left: transverse 
view, right: longitudinal view), irregular spiculated hypoechoic mass 
is seen and classifi  ed as BI-RADS category 4c. Result of  sonography-
guided 14-gauge core needle biopsy indicates stromal fi  brosis, 
which was considered as discordant benign. C. Surgically excised 
specimen reveals widespread dense stromal fi  brosis without ductal cell 
hyperplasia (arrow). Final diagnosis was stromal fi  brosis (Hematoxylin 
& Eosin staining; original magnifi  cation, × 100).Korean J Radiol 12(2), Mar/Apr 2011 www.kjronline.org 237
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BI-RADS Final Assessment Category in Imaging-
Pathology Correlation
Since the establishment of BI-RADS for sonography in 
2003, the reliability of the sonographic BI-RADS lexicon 
or classifi  cation in evaluating sonographic masses for the 
likelihood of malignancy have been assessed and reported 
to have a good performance (10-13). Based on the BI-RADS 
category, the indication for biopsy of particular lesions can 
be clarifi  ed. 
A category 3 lesion is judged to have a 2% or lower 
probability of malignancy and suggested to be followed 
up with short-term imaging surveillance. While performing 
a biopsy is contradictory to a category 3 lesion, it is 
performed in a specifi  c circumstance such as physician or 
patient preference. For a category 3 lesion, a benign core 
biopsy result can be regarded as concordant benign and 
a malignant core biopsy result as discordant malignant. 
However, subtle suspicious sonographic features are 
sometimes overlooked because the fi  nal assessment 
category is determined based on the individual radiologist’s 
experience and training as well as published criteria. In 
imaging-pathology correlation, therefore, the sonographic 
features, even for category 3 lesions, should be reviewed 
based on the strict criteria to avoid missing cancer. 
While BI-RADS category 4 lesions have been 
recommended for biopsy, a wide range of positive predictive 
value (3% to 94%) is problematic. A new recommendation 
in the fourth edition of BI-RADS is for category 4 to be 
subdivided internally into three subgroups (4a, 4b, and 
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Fig. 6. 65-year-old woman with mass 
in her right breast. 
A. On mammography (left: mediolateral 
oblique view, right: craniocaudal view), 
indistinct mass (arrows) is present in  
right breast. B. On sonography (left: 
transverse view, right: longitudinal view), 
oval hypoechoic mass with angular or ill-
defi  ned margin is seen and classifi  ed as 
BI-RADS category 4c. After performing 
sonography-guided 14-gauge core needle 
biopsy, biopsy result was fi  brocystic 
change, which is considered as discordant 
benign. C. Surgical specimen shows lesion 
consisting of extensive ductal carcinoma in 
situ with lobular cancerization. Relatively 
monotonous cells with low-grade nuclei 
and abundant, eosinophilic cytoplasm 
in form of cribriform pattern (arrow) are 
noted (Hematoxylin & Eosin staining; 
original magnifi  cation, × 200).Korean J Radiol 12(2), Mar/Apr 2011 www.kjronline.org 238
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4c) on the basis of the likelihood of malignancy, although 
optional (14). The BI-RADS did not set out specifi  c 
guidelines regarding what was the risk of malignancy for 
each of the subcategories should represent. However, Bent 
et al. (15) suggested that the guidance range of malignancy 
likelihood should be 2-10% for category 4a, 11-50% for 
category 4b, and 51-95% for category 4c. In a study of 
categorizing lesions by mammography or sonography (11), 
PPV was 6%, 15%, and 53% for categories 4a, 4b, and 4c, 
respectively. Whereas, Lee et al. (13) reported that PPV for 
sonography was 26%, 83%, and 91% for category 4a, 4b, 
and 4c, respectively. The interobserver variability and poor 
stratifi  cation for the risk of malignancy in the subcategories 
could be explained by the lack of known factors clearly 
and objectively defi  ning each subdivision. Because the 
use of subcategories is optional and clinical data of those 
subcategories are limited, management is not standardized. 
Based on BI-RADS (14), the benign core biopsy result may 
be regarded as concordant benign and the malignant core 
biopsy result as discordant malignant for a category 4a 
lesion. The benign core biopsy result may be regarded as 
discordant benign and the malignant core biopsy result as 
concordant malignant for a category 4c lesion. For category 
4b lesions, close imaging and pathologic correlations are 
needed. Further studies are needed to evaluate the role of 
these subdivisions in stratifying the level of suspicion and 
the use of this information in management decisions.
In conclusions, careful imaging-pathology correlation 
and appropriated post-biopsy management should be 
the cornerstone of a successful core biopsy program. It 
will allow the detection of a substantial number of false-
negative results immediately after core needle biopsy 
Fig. 7. 36-year-old woman with palpable mass in her right breast. 
A. On sonography (left: transverse view, right: longitudinal view), round microlobulated hypoechoic mass with microcalcifi  cations and nonparallel 
orientation (arrowheads) is seen and classifi  ed as BI-RADS category 4c. Results of sonography-guided 14-gauge core needle biopsy indicate 
presence of stromal sclerosis, which is considered as discordant benign. B. Final diagnosis after surgical excision was invasive ductal carcinoma. 
Photomicrograph of microscopic specimen after surgical excision shows carcinoma within sclerotic stroma (Hematoxylin & Eosin staining; original 
magnifi  cation, × 40).
B A
Fig. 8. 40-year-old woman with palpable mass in her left breast. 
A. On sonography (left: transverse view, right: longitudinal view), oval microlobulated hypoechoic mass with echogenic halo and nonparallel 
orientation is seen and classifi  ed as BI-RADS category 4b. Result of sonography-guided 14-gauge core needle biopsy indicates fi  broadenoma, 
which is considered as discordant benign. B. Surgically excised specimen reveals well circumscribed, lobulated mass with tumoral fl  orid adenosis, 
consistent with adenosis tumor (Hematoxylin & Eosin staining; original magnifi  cation, × 100).
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Fig. 9. 49-year-old woman with mass in her left breast. 
A. On sonography (left: transverse view, right: longitudinal view), oval 
ill-defi  ned hypoechoic mass (arrowheads) is seen and classifi  ed as BI-
RADS category 4a. Results of sonography-guided 14-gauge core needle 
biopsy indicate presence of atypical intraductal papilloma and atypical 
ductal hyperplasia, which is considered as borderline or high-risk. B, 
C. At photomicrograph of microscopic specimen after surgical excision 
(B: Hematoxylin & Eosin staining; original magnifi  cation, × 10), ductal 
carcinoma in situ (upper and lower left; arrowheads) and atypical 
intraductal papilloma (upper right; arrow) are shown. At high-power 
fi  eld (C: Hematoxylin & Eosin staining; original magnifi  cation, × 100), 
ductal carcinoma in situ with low grade, cribriform pattern (left), as 
well as an atypical papilloma with central intraductal papilloma pattern 
and peripheral atypical ductal hyperplasia pattern in largest duct (right) 
are shown. 
C
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Fig. 10. 49-year-old woman with palpable mass in her left 
breast. 
A. On mediolateral oblique view of mammography, oval obscured mass 
(arrow) is shown in left breast. B. On sonography (left: transverse view, 
right: longitudinal view), oval circumscribed hypoechoic mass is seen 
and classifi  ed as BI-RADS category 3. Results of sonography-guided 14-
gauge core needle biopsy performed by request of physician indicate 
presence of benign phyllodes tumor, which is considered as borderline 
or high-risk. C. Photomicrograph of microscopic specimen after surgical 
excision shows relatively ill-defi  ned border, elongated epithelial-lined 
clefts, and mild increase in stromal cellularity with periductal stromal 
accentuation (arrowheads), consistent with benign phyllodes tumor 
(Hematoxylin & Eosin staining; original magnifi  cation, × 100).Korean J Radiol 12(2), Mar/Apr 2011 www.kjronline.org 240
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by identifying discordant lesions prospectively, thereby 
avoiding delays in the diagnosis of cancer. Although the 
communication between the radiologist and pathologist is 
the basis of imaging-pathology correlation, establishing 
concordance is subject to the experience of the radiologist. 
The radiologist performing the biopsy must be familiar with 
the imaging features of a vast array of pathologic breast 
lesions and they must be able to correlate with each other.
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